Skip to content

Double Lumen Tube Intubation

Comparison of Techniques for Double-lumen Tube Intubation: Standard Double-lumen Tube or VivaSight Double Lumen Tube by Paramedics. A Randomized Crossover Manikin Trial.

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02295657
Acronym
DLETI
Enrollment
120
Registered
2014-11-20
Start date
2014-11-30
Completion date
2014-12-31
Last updated
2014-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Endotracheal Intubation

Brief summary

The aim of this study was to compare time, success rates of different double-lumen tubes in intubation in a standardized manikin model.

Interventions

intubation using standard double-lumen tube

intubation using VivaSight Double Lumen Tube

Sponsors

International Institute of Rescue Research and Education
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* give voluntary consent to participate in the study * minimum 1 year of work experience in emergency medicine * experienced emergency medicine personnel (physicians, nurses, paramedics)

Exclusion criteria

* not meet the above criteria * wrist or low back diseases

Design outcomes

Primary

MeasureTime frameDescription
Success of intubation1 dayeffectiveness of first, second and third intubation attempts and overall effectiveness of intubation by participants

Secondary

MeasureTime frameDescription
Intubation time1 daytime in seconds required for a successful intubation attempt
Cormack-Lehane grading1 dayself-reported percentage the vocal cord visualization using the Cormack-Lehane grading (grade 1-4)
Preferred ETI device1dayparticipants were asked which method of ETI they would prefer in a real-life.

Countries

Poland

Contacts

Primary ContactAndrzej Kurowski
andrzejkurowski987@gmail.com+48500186225

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026